99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: Preclinical evaluation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 10, 2011, Pages 1832-1841

  Pesnel, Sabrina ^a,b   Guminski, Yves ^a   Pillon, Arnaud ^a   Lerondel, Stéphanie ^b   Imbert, Thierry ^a   Guilbaud, Nicolas ^a   Kruczynski, Anna ^a   Bailly, Christian ^a   Le Pape, Alain ^b,c  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

Cancer; F14512; Polyamine transport; Scintigraphic imaging; Spermine

Indexed keywords

HYDRAZINONICOTINAMIDE; NICOTINAMIDE; POLYAMINE; POLYAMINE TRANSPORT SYSTEM; SPERMINE; TECHNETIUM 99M; UNCLASSIFIED DRUG; CARRIER PROTEIN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; HYDRAZINE DERIVATIVE; HYDRAZINO NICOTINAMIDE; TECHNETIUM 99M HYNIC SPERMINE; TECHNETIUM 99M HYNIC-SPERMINE; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER CELL; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PURITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTERNALIZATION; ISOTOPE LABELING; LEUKEMIA; LUNG CARCINOMA; MALE; MELANOMA CELL; MOUSE; MUSCLE; NONHUMAN; PLASMA; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR; ANIMAL; CHEMISTRY; DRUG STABILITY; FEMALE; HUMAN; LUMINESCENCE; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; NEOPLASM; PATHOLOGY; RADIOCHEMISTRY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE, TUMOR; DRUG STABILITY; FEMALE; HUMANS; HYDRAZINES; LUMINESCENT MEASUREMENTS; MALE; MICE; MOLECULAR IMAGING; NEOPLASMS; NIACINAMIDE; ORGANOTECHNETIUM COMPOUNDS; RADIOCHEMISTRY; SPERMINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 80455174030     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1857-2     Document Type: Article

References (20)

1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
2. van der Meel R, Gallagher WM, Oliveira S, O'Connor AE, Schiffelers RM, Byrne AT. Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies. Drug Discovery Today 2010;15:102-14.
3. Vidal Melo MF, Winkler T, Harris RS, Musch G, Greene RE, Venegas JG. Spatial heterogeneity of lung perfusion assessed with (13) N PET as a vascular biomarker in chronic obstructive pulmonary disease. J Nucl Med 2010;51:57-65.
4. Larson SM, Schwartz LH. 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology. J Nucl Med 2006;47:901-3. (Pubitemid 46939939)
5. Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, et al. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain 2009;132:1067-77.
6. Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 2007;130:2616-35. (Pubitemid 47511706)
7. Barret JM, Kruczynski A, Vispé S, Annereau JP, Brel V, Guminski Y, et al. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system. Cancer Res 2008;68:9845-53.
8. Kruczynski A, Vandenberghe I, Pillon A, Pesnel S, Goetsch L, Barret JM, et al. Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system. Invest New Drugs 2011;29:9-21.
9. Holley JL, Mather A, Wheelhouse RT, Cullis PM, Hartley JA, Bingham JP, et al. Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate. Cancer Res 1992;52:4190-5.
10. Wang C, Delcros JG, Cannon L, Konate F, Carias H, Biggerstaff J, et al. Defining the molecular requirements for the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J Med Chem 2003;46:5129-38. (Pubitemid 37414183)
11. Delcros JG, Tomasi S, Carrington S, Martin B, Renault J, Blagbrough IS, et al. Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine. J Med Chem 2002;45:5098-111. (Pubitemid 35278706)
12. Siddiqui AQ, Merson-Davies L, Cullis PM. The synthesis of novel polyamine-nitroimidazole conjugates designed to probe the structural specificities of the polyamine uptake system in A549 lung carcinoma cells. J Chem Soc Perkin 1 1999;22:3243-52.
13. Seiler N, Delcros JG, Moulinoux JP Polyamine transport in mammalian cells. An update. Int J Biochem Cell Biol 1996;28:843-61. (Pubitemid 26284212)
14. Guminski Y, Grousseaud M, Cugnasse S, Brel V Annereau JP Vispé S, et al. Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system. Bioorg Med Chem Lett 2009;19:2474-7.
15. Annereau JP, Brel V, Dumontet C, Guminski Y, Imbert T, Broussas M, et al. A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment. Leuk Res 2010;34:1383-9.
16. Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990;31:2022-8.
17. Geall AJ, Blagbrough IS. Homologation of polyamines in the rapid synthesis of lipospermine conjugates and related lipoplexes. Tetrahedron 2000;56:2449-60. (Pubitemid 30232985)
18. Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kidney Int 2006;69:440-9. (Pubitemid 43164434)
19. Surfraz MB, King RC, Mather SJ, Biagini S, Blower PJ. Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids. J Inorg Biochem 2009;103:971-7.
20. King RC, Surfraz MB, Biagini SC, Blower PJ, Mather SJ. How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studies. Dalton Trans 2007;21:4998-5007. (Pubitemid 350015423)